Clinical Trials Logo

Clinical Trial Summary

Metabolic surgery, as a recognition treatment option for patients with clinical morbid obesity, is gaining increasing appreciation. In addition to substantial weight loss, emerging studies have highlighted that metabolic surgery can substantially ameliorate obesity-related metabolic diseases, including but not limited to type 2 diabetes mellitus (T2DM), hypertension, dyslipidemia, obstructive sleep apnea-hypopnea syndrome (OSAHS) and polycystic ovary syndrome (PCOS)in severely obese patients. However, further investigations with larger sample size and longer observation time still needed to clarity the efficacy and safety of metabolic surgery in Chinese patients with obesity and encouraging future research in this field.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03800160
Study type Observational [Patient Registry]
Source Beijing Friendship Hospital
Contact
Status Enrolling by invitation
Phase
Start date April 1, 2018
Completion date April 1, 2029

See also
  Status Clinical Trial Phase
Recruiting NCT03467581 - Five-year Outcome of Laparoscopic Gastric Sleeve N/A
Suspended NCT03412253 - Could Single-anastomosis Gastric Bypass Be a Curative Treatment for Type II Diabetes? N/A
Recruiting NCT06275061 - Chinese Obesity and MEtabolic Surgery Database (COMES Database)
Recruiting NCT02749305 - Comparative Effectiveness of Bariatric Surgery With PROMs N/A
Completed NCT04609449 - A Comparison Between Short vs. Long Biliopancreatic Limb Gastric Bypass N/A
Recruiting NCT03891056 - Metabolic Surgery; Gastric Bypass vs Sleeve Gastrectomy; Efects Over Type 2 DM With Bad Metabolic Control (MSO1CT) N/A
Completed NCT02301416 - Qsymia as an Adjunct to Surgical Therapy in the Superobese Phase 2
Recruiting NCT03520699 - Beijing Friendship Hospital Metabolic Surgery Database